Search Results - "Group, Representing Korea Pranlukast Study"

Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial by Yoo, S H, Park, S H, Song, J S, Kang, K H, Park, C S, Yoo, J H, Choi, B W, Hahn, M H

“…Leukotriene antagonists are increasingly used in asthma management. Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene receptor. The…”
Get full text

Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: A 4 week randomized multicentre controlled trial by Yoo, Se Hwa, Park, Sung Hak, Song, Jeong Sup, Kang, Kyung Ho, Park, Choon Sik, Yoo, Jee Hong, Choi, Byoung Whui, Hahn, Myung Ho, Group, Representing Korea Pranlukast Study

“…Objective: Leukotriene antagonists are increasingly used in asthma management. Pranlukast is a new, orally active, selective inhibitor of CysLt1 leukotriene…”
Get full text